Thermo Fisher Scientific announces redemption of outstanding 3.25% Convertible Notes

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has given notice of its intention to redeem all of the outstanding 3.25% Convertible Senior Subordinated Notes due 2024 (the "Notes").

As of February 25, 2011, $329,229,000 million in aggregate principal amount of the Notes was outstanding. In accordance with the terms of the indenture governing these Notes, they will be redeemed on March 30, 2011 (the "Redemption Date"), at 100% of their principal amount plus accrued and unpaid interest to the Redemption Date.

The Notes are convertible at any time prior to March 29, 2011, at a rate of 24.8756 shares of common stock per $1,000 principal amount of the Notes surrendered. The Notes surrendered for conversion will be settled in cash in accordance with the provisions of the indenture.

The Bank of New York Mellon, the trustee for the 2024 Convertible Notes, is mailing a Notice of Redemption to all registered holders of the Notes today. Copies of such Notice of Redemption and additional information relating to the procedure for redemption and/or conversion of the Notes may be obtained from The Bank of New York Mellon by calling 800-254-2826.

Source:

Thermo Fisher Scientific Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 19). Thermo Fisher Scientific announces redemption of outstanding 3.25% Convertible Notes. News-Medical. Retrieved on January 22, 2021 from https://www.news-medical.net/news/20110228/Thermo-Fisher-Scientific-announces-redemption-of-outstanding-32525-Convertible-Notes.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces redemption of outstanding 3.25% Convertible Notes". News-Medical. 22 January 2021. <https://www.news-medical.net/news/20110228/Thermo-Fisher-Scientific-announces-redemption-of-outstanding-32525-Convertible-Notes.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces redemption of outstanding 3.25% Convertible Notes". News-Medical. https://www.news-medical.net/news/20110228/Thermo-Fisher-Scientific-announces-redemption-of-outstanding-32525-Convertible-Notes.aspx. (accessed January 22, 2021).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific announces redemption of outstanding 3.25% Convertible Notes. News-Medical, viewed 22 January 2021, https://www.news-medical.net/news/20110228/Thermo-Fisher-Scientific-announces-redemption-of-outstanding-32525-Convertible-Notes.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies